Cited by 470Cervical Cancer and HPV ResearchWomen's cancer prevention and managementReproductive tract infections research

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis

Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., Matchar, D. B.·2000·American Journal of Epidemiology

DOI 10.1093/oxfordjournals.aje.a010166

Open this paper in CoChat — free account

Abstract

The authors constructed a Markov model as part of a systematic review of cervical cytology conducted at the Duke University Evidence-based Practice Center (Durham, North Carolina) between October 1997 and September 1998. The model incorporated states for human papillomavirus infection (HPV), low- and high-grade squamous intraepithelial lesions, and cervical cancer stages I-IV to simulate the natural history of HPV infection in a cohort of women from ages 15 to 85 years. The age-specific incidence rate of HPV, and regression and progression rates of HPV and squamous intraepithelial lesions, were obtained from the literature. The effects of varying natural history parameters on cervical cancer incidence were evaluated by using sensitivity analysis. The base-case model resulted in a lifetime cervical cancer risk of 3.67% and a lifetime cervical cancer mortality risk of 1.26%, with a peak incidence of 81/100,000 at age 50 years. Age-specific distributions of precursors were similar to reported data. Lifetime risk of cancer was most sensitive to the incidence of HPV and the probability of rapid HPV progression to high-grade lesions (two- to threefold variations in risk). The model approximates the age-specific incidence of cervical cancer and provides a tool for evaluating the natural history of HPV infection and cervical cancer carcinogenesis as well as the effectiveness and cost-effectiveness of primary and secondary prevention strategies.

Integrity signals

Registry

Crossref · 10.1093/oxfordjournals.aje.a010166

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia
SCHIFFMAN, M. H., Bauer, H. M., Hoover, R. N., Glass, A. G., Cadell, D. M., Rush, B. B., Scott, D. R., Sherman, M. E., Kurman, R. J., Wacholder, S., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.12.958 · Cited by 1,197
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, L. A. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,103
A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J. A., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 940
Screening for Cervical Cancer
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 841
Meta-analysis of Pap Test Accuracy
Fahey, M. T., Irwig, L., & Macaskill, P. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117485 · Cited by 690
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., SCHIFFMAN, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics
Quinn, M. A., Babb, P., Jones, J., & Allen, E. (1999) · BMJ · doi:10.1136/bmj.318.7188.904 · Cited by 571
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women
Moscicki, A., Shiboski, S. C., Broering, J. M., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R. J., Kanowitz, S., Miller, S., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70445-7 · Cited by 562

Show all 49 references

Sorted by citations

Items 301–400 of 467

Human Papillomavirus and HPV Vaccines
Eliscu, A. H. (2017) · Pediatrics in Review · doi:10.1542/pir.2016-0018 · Cited by 8
Human Papillomavirus and Genital Warts
Goldman, L., & Clouse, A. L. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-499-9_1 · Cited by 8
Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom Analysis
Castañeda, K. M., Vermeulen, K. M., van Asselt, A. D. I., Schuuring, E. M. D., Wisman, G. B. A., Greuter, M. J. W., & de Bock, G. H. (2025) · Cancers · doi:10.3390/cancers17040612 · Cited by 7
Mathematical modelling in health care
Karnon, J. D., Mackay, M. F., & Mills, T. (2009) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 7
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays
Cricca, M. (2003) · Journal of Clinical Virology · doi:10.1016/s1386-6532(03)00109-4 · Cited by 7
A cost‐effectiveness analysis of four management strategies in the determination and follow‐up of atypical squamous cells of undetermined significance
Hughes, A. A., Glazner, J. E., Barton, P. L., & Shlay, J. C. (2005) · Diagnostic Cytopathology · doi:10.1002/dc.20210 · Cited by 7
Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study
Khiari, H., Makni, K., Meddeb, K., Jaïdane, O., & Hsaïri, M. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-085462 · Cited by 6
The four steps in the prevention of human papillomavirus-associated neoplasia
Liverani, C. A. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3011-9 · Cited by 6
Impact of HPV vaccination: health gains in the Italian female population
Marcellusi, A. (2017) · Population Health Metrics · doi:10.1186/s12963-017-0154-0 · Cited by 6
Modelling the impact of referral guideline changes for mild dyskaryosis on colposcopy services in England
Eggington, S., Hadwin, R. J., Brennan, A., & Walker, P. (2006) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 6
Cancer Precursors
Rohan, T. E., Henson, D. E., Franco, E. L., & Albores‐Saavedra, J. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0003 · Cited by 6
The effect of hrHPV prevalence on cervical cancer screening strategies: a cost-effectiveness study of Bangladesh
Pan, F., van der Schans, J., Nazrul, N., Koot, J. A. R., Beltman, J. J., Greuter, M. J. W., & de Bock, G. H. (2025) · BMC Public Health · doi:10.1186/s12889-025-21756-x · Cited by 6
A mathematical analysis of human papilloma virus (HPV) disease with new perspectives of fractional calculus
Abdeljawad, T., Khan, N., Abdalla, B., Al-Jaser, A., Alqudah, M. A., & Shah, K. (2025) · Alexandria Engineering Journal · doi:10.1016/j.aej.2025.03.136 · Cited by 5
Cost-Effectiveness and Budget Impact Analysis of Primary Screening With Human Papillomavirus Test With Genotyping in Argentina
Garay, O. U., Furcada, J. M., Ayerbe, F., Rave, R. A. P. R., & Tatti, S. (2021) · Value in Health Regional Issues · doi:10.1016/j.vhri.2021.07.004 · Cited by 5
Evaluating the cost-effectiveness of HPV vaccination for adolescent girls in Japan: A comparison of 2-valent, 4-valent, and 9-valent HPV vaccines with consideration of cross-protection
Choi, W., & Shim, E. (2023) · Preventive Medicine · doi:10.1016/j.ypmed.2023.107743 · Cited by 5
Diagnosis and management of HPV-related anal dysplasia
Greene, M. D. (2009) · The Nurse Practitioner · doi:10.1097/01.npr.0000350571.53729.74 · Cited by 5
Evidence Supporting the Current Management Guidelines for High-Grade Squamous Intraepithelial Lesion Cytology
Padilla-paz, L. A., Carlson, J. W., Twiggs, L. B., Lonky, N. M., Crum, C. P., Felix, J. C., Hunter, V. J., Krumholz, B. A., Massad, L. S., & Benedet, J. L. (2004) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200404000-00010 · Cited by 5
APPLICATION OF DYNAMIC BAYESIAN NETWORKS TO RISK ASSESSMENT IN MEDICINE
Oniśko, A. (2010) · Cited by 5
El virus del papiloma humano y su repercusión en la patología genital femenina
Rodríguez‐Cerdeira, C., Menéndez, A. A., Jaso, G. B., & Cáceres, R. A. (2007) · Piel · doi:10.1016/s0213-9251(07)73045-9 · Cited by 5
Inverse decision theory with applications to screening and diagnosis of cervical intraepithelial neoplasia
Davies, K., Cox, D. D., Swartz, R. J., Cantor, S. B., & Follen, M. M. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.07.053 · Cited by 5
Disease prevention without relapse: Processes of change for HPV vaccination
Fernandez, A. C., Paiva, A. L., Lipschitz, J. M., Larson, H. E., Amoyal, N. R., Blaney, C. L., Sillice, M. A., Redding, C. A., & Prochaska, J. O. (2013) · Open Journal of Preventive Medicine · doi:10.4236/ojpm.2013.33041 · Cited by 5
A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study
Carter, R. L., Kang, L., Darcy, K. M., Kauderer, J. T., Liao, S., Rodgers, W. H., Walker, J. L., Lankes, H. A., Dunn, S. T., & Stanbridge, E. J. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0081-0 · Cited by 5
Vaccines against human papillomavirus: perspectives for controlling cervical cancer
Carrancá, A. G., & Galván, S. C. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.4.497 · Cited by 5
Entscheidungsanalytische Modellierung zur Evaluation der Langzeit-Effektivität und Kosten-Effektivität des Einsatzes der HPV-DNA-Diagnostik im Rahmen der Zervixkarzinomfrüherkennung in Deutschland
Sroczynski, G., Schnell‐Inderst, P., Mühlberger, N., Lang, K., Aidelsburger, P., Wasem, J., Mittendorf, T., Engel, J., Hillemanns, P., Petry, K. U., et al. (2010) · Publikationen an der Universität Bielefeld (Universität Bielefeld) · doi:10.3205/hta000083l · Cited by 5
Human papillomavirus vaccine and cervical cancer prevention
Oaknin, A., & Barretina, M. P. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0293-7 · Cited by 5
Harms and benefits of cervical cancer screening among non-attenders in Switzerland: The transition towards HPV-based screening
Catarino, R., Vassilakos, P., Petignat, P., & Combescure, C. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101929 · Cited by 4
At the Interface between Acute and Chronic Inflammation
Yoram Vodovotz, B. (2012) · CRC Press eBooks · doi:10.1201/b12696-3 · Cited by 4
Online Cost-Effectiveness ANalysis (OCEAN): a user-friendly interface to conduct cost-effectiveness analyses for cervical cancer
Moriña, D., Martí, J. I., Puig, P., & Díaz, M. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01232-9 · Cited by 4
Clinical Performance of Cobas 6800 for the Detection of High-Risk Human Papillomavirus in Urine Samples
Hajjar, B., Raheel, U., Manina, R., Simpson, J., Irfan, M. I., & Waheed, Y. (2023) · Vaccines · doi:10.3390/vaccines11061071 · Cited by 4
Dynamic Bayesian Network for Cervical Cancer Screening
Oniśko, A., & Austin, R. M. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-28007-3_13 · Cited by 4
Impact of HPV-16 Lineages Infection in Response to Radio-Chemotherapy in Cervical Cancer
de Figueiredo, F. V., dos Santos, G. R. B., Vidal, F. C. B., da Silva, M. A. C. N., da Silva, R. L., Batista, Z. D. S., de Andrade, M. S., Barbosa, M. D. C. L., Maniçoba, A. C. B. N., Silva, M. C. P. D., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11072069 · Cited by 4
Human Papillomavirus Carcinogenicity and the Need of New Perspectives: Thoughts from a Retrospective Analysis on Human Papillomavirus Outcomes Conducted at the Hospital University of Bari, Apulia, Italy, between 2011 and 2022
Prete, R. D., Nesta, D., Triggiano, F., Lorusso, M., Garzone, S., Vitulano, L., Denicolò, S., Indraccolo, F., Mastria, M., Ronga, L., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14090968 · Cited by 7
Trends of cervical tumours amongst women from perspectives of demographic, socioeconomic and geographic indicators: retrospective ecological study in Czechia
Holý, O., Machaczka, O., Schovankova, T., Navrátilová, D., Zimmermannová, J., Klasterecka, R., & Vévoda, J. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1347800 · Cited by 4
Public Health and Prevention
Meites, E., & Workowski, K. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-499-9_12 · Cited by 4
Human Papillomavirus: Epidemiology and Clinical Features of Related Cancer
Mayo, T. T., Imtiaz, R., Doan, H. Q., Sambrano, B. L., Gordon, R., Ramirez‐Fort, M. K., & Tyring, S. K. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0870-7_9 · Cited by 4
Environmental and Genetic Factors Contributing to Bladder Carcinogenesis
Dason, S., & Wong, N. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-82048-0_2 · Cited by 4
Management strategies and cost effectiveness in the prevention of cervical cancer
Prasad, S. R. (2009) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s4226 · Cited by 4
Evaluation of commercial kits for the detection and typing of human papillomavirus in cervical swabs
Venturoli, S., Bonvicini, F., Cricca, M., Gallinella, G., Giosa, F., Farinazzo, F., Stefanuto, G., Musiani, M., & Zerbini, M. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(02)00066-6 · Cited by 4
Atopic patients with genital warts have a more protracted clinical course and a greater probability of recurrences
Stefanaki, C., Stefanaki, I., Verra, P., Hadjivassiliou, M., Caroni, C., Bethimoutis, G., Papadogeorgaki, H., Stavropoulos, P., Kostaki, M., Antoniou, C., et al. (2010) · International Journal of STD & AIDS · doi:10.1258/ijsa.2010.010225 · Cited by 4
Human papillomaviruses in cervical screening
Jenkins, D. (2001) · Current Diagnostic Pathology · doi:10.1054/cdip.2001.0061 · Cited by 4
Human papillomavirus driving cervical cancer: A mathematical model with persistent infection, cancer progression, and spontaneous remission
Hayashi, R., Hara, A., & Iwasa, Y. (2025) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2025.112289 · Cited by 3
Research on the relationship between HPV infection and alterations in vaginal microbial ecology
Guo, M., Chen, C., Wang, W., Zhang, C., Ma, J., Sadike, M., Niyazi, M., Feng, X., & Zhu, K. (2025) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2025.07.008 · Cited by 3
Lifestyle Factors and Health Risk Behaviors
Tyc, V. L., & Klosky, J. L. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7584-3_21 · Cited by 3
Predictors associated with and the prevalence of condylomata acuminata infection among people in Southern Brazil
de Peder, L. D., da Silva, C. M., Madeira, H. S., Malizan, J. A., Nascimento, B. L., Dranka, J. A. H., Silva, E. S., & Teixeira, J. J. V. (2021) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v11i1.1021 · Cited by 3
Labial Edema Following Treatment of Condyloma Acuminata with CO2 Laser in an Adolescent: A Case Report and Literature Review
Levavi, H., Peretz-Davidi, Y., & Sabah, G. (2006) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2006.01.049 · Cited by 3
Markov Models for the Simulation of Cancer Screening Process
Chiorean, I., Lupşa, L., & Neamţiu, L. (2008) · AIP conference proceedings · doi:10.1063/1.2990876 · Cited by 3
Que hay en el horizonte sobre el virus del papiloma humano, vacunas y el control del cáncer cervical
Garcia, P. J. (2007) · Americanae (AECID Library) · doi:10.17843/rpmesp.2007.243.1120 · Cited by 3
Sağlık Araştırmalarında Matematik Model Kullanımı
Yaylalı, E. (2020) · Online Türk Sağlık Bilimleri Dergisi · doi:10.26453/otjhs.773674 · Cited by 3
Knowledge, attitude and practice study about HPV and its vaccination among medical college students in North India
Kumar, A., & Garg, P. (2020) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20205042 · Cited by 3
Análise de custo-efetividade de estratégias de rastreamento do câncer do colo do útero no Brasil
Viscondi, J. Y. K. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-20022018-091434 · Cited by 3
A comparison of the cost-effectiveness of HPV (self-sampling and health care provider sampling) versus VIA for cervical cancer screening in India
Pant, A., Thangavel, G., Mathew, S., & Nath, A. (2025) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2025.100642 · Cited by 2
Significance of negative cervical cytology and positive HPV in the diagnosis of cervical lesions by colposcopy
Zhang, C., Liu, D., Liu, K., Xiao, H., Si, H., Wang, X., & Wang, H. (2024) · Open Medicine · doi:10.1515/med-2024-1051 · Cited by 2
Update on strategies of controlling sexually transmitted infections: Taiwan experience
Tsai, C.-C., Wang, Y.-Y., Chou, Y., Li, C., & Wu, W. (2016) · Urological Science · doi:10.1016/j.urols.2016.09.003 · Cited by 2
Cervical Cancer Stem Cells and Their Association with Human Papillomavirus: Are They Ready as Anticancer Targets?
Vishnoi, K., Tyagi, A., Singh, S. M., Das, B. C., & Bharti, A. C. (2014) · Springer eBooks · doi:10.1007/978-3-319-12253-3_24 · Cited by 2
A hybrid fractional model for cervical cancer due to human papillomavirus infection
Akgül, A., Ahmed, N., Rano, S. A., & Al‐Mdallal, Q. M. (2025) · International Journal of Thermofluids · doi:10.1016/j.ijft.2025.101098 · Cited by 2
Immunogenicity, Efficacy, Effectiveness and Overall Impact of HPV Vaccines
Lehtinen, M., Nieminen, P., Apter, D. L., Namujju, P., Natunen, K., Rana, M., & Paavonen, J. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1988-4_10 · Cited by 2
Cost-effectiveness Analysis of 2 Surveillance Options for Cervical Intraepithelial Neoplasia 1
Savage, A. H., Marlow, N. M., Alkis, M. H., & Simpson, K. N. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31829eaf31 · Cited by 2
[Human papillomavirus infection, cervical cancer and their involvement in head and neck cancer].
良, 今. (2012) · Nippon Jibiinkoka Gakkai Kaiho · doi:10.3950/jibiinkoka.115.73 · Cited by 2
Acceptabililty of HPV vaccination among women attending the University of Saskatchewan student health services
Giede, C. K., McFadden, L. L., Komonoski, P., Agrawal, A., Stauffer, A., & Pierson, R. A. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.10.036 · Cited by 2
Estimación de la carga económica de las lesiones preneoplásicas y el cáncer de cuello uterino en Colombia. Implicaciones para la vacunación contra el VPH
Gamboa, Ó., & Murillo, R. (2016) · Revista Colombiana de Cancerología · doi:10.1016/j.rccan.2016.02.004 · Cited by 2
In-vitro Anticancer activity of Boerhaavia diffusa Linn.
R.Venkatajothi, D. (2017) · International Journal of Current Research in Biology and Medicine · doi:10.22192/ijcrbm.2017.02.03.004 · Cited by 2
Interferon lambda4 polymorphism is not associated with human papillomavirus infection outcome
Cannella, F., Scagnolari, C., Statzu, M., Sciandra, I., Recine, N., d’Ettorre, G., Antonelli, G., & Pierangeli, A. (2017) · Virus Genes · doi:10.1007/s11262-017-1527-y · Cited by 2
Human papilloma virus vaccination: knowledge, awareness and acceptability among medical and paramedical students
Hoblidar, S., Moni, S., Desai, R. M., & Neravi, A. (2019) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20196071 · Cited by 2
Sexually Transmitted Diseases (STDs)
Cocci, A., & Romano, A. (2022) · Management of urology · doi:10.1007/978-3-031-12049-7_17 · Cited by 2
Evaluation of knowledge and attitudes of the faculty of medicine students about human papillomavirus infections, related cancers, and human papillomavirus vaccines
Yağan, Z., Aldanmaz, A., Ertuğrul, T., Tolan, Z. B., Bilgiç, A. M., & Bilgiç, A. (2023) · TURKDERM · doi:10.4274/turkderm.galenos.2023.31899 · Cited by 2
Molecular Basis of Gynecologic Diseases
Mok, S. C., Wong, K., Lu, K. H., Münger, K., & Nagymányoki, Z. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00023-8 · Cited by 2
Human Papillomavirus and Genital Warts
Goldman, L. (2006) · Humana Press eBooks · doi:10.1007/978-1-59745-040-9_2 · Cited by 2
Oxidative Stress in the Pathogenesis of Cervical Cancer
Santosh, W., Freddy, A. J., & Winkins, D. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_277 · Cited by 2
The Relationship Between Knowledge and Beliefs About Human Papillomavirus, Acceptance of the Human Papillomavirus Vaccine, and Intentions to Practice Safer Sex Behaviors Among Female College Students
Scorcia-Wilson, T. (2010) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
Modelling healthcare provision for an infectious disease using optimal control
Brown, V. (2010) · The University of Bath Online Publications Store (The University of Bath) · Cited by 2
Markov models to estimate and describe survival time and experience in cohorts with high euthanasia frequency
Hosgood, G. L. (2002) · doi:10.31390/gradschool_dissertations.963 · Cited by 2
Hierarchical Hidden Markov Jump Processes for Cancer Screening ModelingPreprint
Meng, R., Braden, S., Nygård, J. F., Nygrad, M., & Lee, H. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1910.05847 · Cited by 2
Research on the relationship between HPV infection and alterations in vaginal microbial ecology
Guo, M., Chen, C., Wang, W., Zhang, C., Ma, J., Sadike, M., Niyazi, M., Feng, X., & Zhu, K. (2025) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2025.07.006 · Cited by 1
Infecciones de transmisión sexual y enfermedad pélvica inflamatoria en las mujeres
Trigg, B. G., Kerndt, P. R., & Aynalem, G. (2008) · Clínicas médicas de Norteamérica · Cited by 1
Cancer du col de l’utérus et dépistage du HPV
Hoonhorst, F., & Hamon, A. (2008) · IRBM News · doi:10.1016/s1959-7568(08)75557-3 · Cited by 1
Recommended Managements for the Male Human Papillomavirus Infection
Han, J. H. (2014) · Korean Journal of Urogenital Tract Infection and Inflammation · doi:10.14777/kjutii.2014.9.2.79 · Cited by 1
Impact of human papillomavirus vaccination on anal cancer incidence in French women
Ribassin-Majed, L. (2012) · Journal of Public Health and Epidemiology · doi:10.5897/jphe11.199 · Cited by 1
Models of HPV as an Infectious Disease and as an Etiological Agent of Cancer.
Brouwer, A. F. (2015) · Cited by 1
A Two-Gender Human Papillomavirus Model with an Investigation of the Effects of Male Screening
Froelich, J., Gant, Z., Majumdar, A., Ortiz-Albino, R. M., & Lanham, M. S. M. (2002) · Cited by 1
HPV Vaccination Policy Mandate
Christopher, K. B. (2012) · Cited by 1
Molecular Basis of Gynecologic Diseases
Mok, S. C., Wong, K., Lu, K. H., Münger, K., & Nagymányoki, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802761-5.00023-7 · Cited by 1
Management of Precancerous Lesions of Cervix
Mandal, R., Kamei, H., Chatterjee, P., & Barmon, D. (2022) · Springer eBooks · doi:10.1007/978-981-19-5860-1_12 · Cited by 1
Estimating the Impact of Prevention Action: A simulation Model of Cervical Cancer Progression
Rosen‐Zvi, M., Shpigelman, L., Kalton, A., Weissbrod, O., Akindeinde, S. O., Benefeldt, S., Andrew, B., Everett, T., Jajinskiji, J., Kweyu, E., et al. (2014) · Studies in health technology and informatics · doi:10.3233/978-1-61499-432-9-288 · Cited by 1
Q & A: Patient to Physician FAQs: Answers to Common Patient Questions About Vaccinations
Trayes, K. P., & Conniff, K. M. (2011) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2011.07.012 · Cited by 1
Apport de la modélisation mathématique à la décision vaccinale.
Lévy-Bruhl, D. (2010) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32184-3 · Cited by 1
Bioinformatics analysis of putative causes for сross-reactive antibodies interacting with antigens derived from various pathogenic human papillomaviruses
Сергеевич, С. А., Salyaev, R. K., & Rekoslavskaya, N. I. (2020) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-tba-1263 · Cited by 1
Should women with HPV-related noncervical cancers be considered at high risk for cervical cancer?
Vegunta, S., & Long, M. E. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.19145 · Cited by 1
The effect of message framing and perceived action risk on young women’s attitudes toward and intentions to get the human papillomavirus (HPV) vaccine
Russell, J. C. (2010) · CSUN ScholarWorks (California State University, Northridge) · Cited by 1
The Pediatrician's Role in Preventing Cervical Cancer
Blatter, M. M., & Monk, B. J. (2008) · Clinical Pediatrics · doi:10.1177/0009922808315219 · Cited by 1
La fin du cancer du col de l'utérus grâce á la vaccination?
Heard, I. (2008) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(08)80046-9 · Cited by 1
El cáncer cervical como problema de salud pública en mujeres mexicanas y su relación con el Virus de papiloma humano
Iñíguez, C. B., & Sara, M. (2005) · TDX (Tesis Doctorals en Xarxa) · Cited by 1
Kosteneffektivität der HPV-Diagnostik in der Zervixkarzinomfrüherkennung
Siebert, U., Sroczynski, G., Marckmann, G., & Hillemanns, P. (2003) · Der Gynäkologe · doi:10.1007/s00129-003-1334-5 · Cited by 1
Planning for human papillomavirus vaccines in Australia: Report of a research group meeting
Brotherton, J. M. L., & McIntyre, P. B. (2004) · Communicable Diseases Intelligence · doi:10.33321/cdi.2004.28.25 · Cited by 1
Avaliação do impacto da capacitação dos Agentes Comunitários de Saúde em doenças sexualmente transmissíveis, no município de São Sebastião do Paraíso-MG
Neves, J. P. D. P. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.22.2016.tde-11102016-153801 · Cited by 1
Lead time and down-staging in the survival of cervical cancer cases detected by screening
Dugué, P., Rebolj, M., & Lynge, E. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.07.025 · Cited by 1
Mailed Self-Sample HPV Testing Kits to Improve Cervical Cancer Screening in a Safety Net Health System: Protocol for a Hybrid Type 2 Randomized Effectiveness-Implementation TrialPreprint
Montealegre, J. R., Anderson, M. L., Hilsenbeck, S. G., Chiao, E. Y., Cantor, S. B., Parker, S., Daheri, M., Bulsara, S., Escobar, B., Deshmukh, A. A., et al. (2020) · doi:10.21203/rs.3.rs-28060/v1 · Cited by 1
Bibliografía recomendada
(2001) · Progresos de Obstetricia y Ginecología · doi:10.1016/s0304-5013(01)75678-6 · Cited by 1
Economic evaluation of a school based human papillomavirus (HPV) vaccination program in South Africa
Thambiran, M. (2015) · UpSpace Institutional Repository (University of Pretoria)
Using Simulation Optimization to Construct Efficient Screening Strategies for Cervical Cancer
Foufoulides, C. (2008) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/5wyp-4w25
Human Papillomavirus Vaccine Policy in the U.S.
Jarrell, J. C. (2022) · Digital Archive @ GSU · doi:10.57709/1062256

Authors: Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B.
Affiliations: Duke University (US)
Corresponding author: Myers, E. R.
ORCID: Myers, E. R.
McCrory, D. C.
Nanda, K.
Bastian, L.
Matchar, D. B.
Venue: American Journal of Epidemiology
Publisher: Oxford University Press (OUP)
Published: 2000-06-15
Volume: 151
Issue: 12
Pages: 1158-1171
ISSN: 0002-9262 (ISSN-L)
1476-6256
DOI: 10.1093/oxfordjournals.aje.a010166
OpenAlex: W2113839478
Cited by: 470
References: 49
Citations by year: 2026: 4 · 2025: 16 · 2024: 8 · 2023: 14 · 2022: 13 · 2021: 17 · 2020: 18 · 2019: 11 · 2018: 19 · 2017: 20 · 2016: 12 · 2015: 22 · 2014: 24 · 2013: 32 · 2012: 19
FWCI: 8.82
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Epidemiology (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (290-97-0014)
Topics: Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords: HPV infection, cervical carcinogenesis, natural history of HPV infection, squamous intraepithelial lesions, cervical cancer incidence, cervical cancer mortality, lifetime cancer risk, Markov model, cervical cancer prevention, sensitivity analysis
MeSH terms: Adolescent, Adult, Aged, Antiviral Agents, Cell Transformation, Neoplastic, Uterine Cervical Neoplasms, Cost-Benefit Analysis, Female, Humans, Markov Chains, Middle Aged, Models, Theoretical, Tumor Virus Infections, Incidence, Risk Assessment, Papillomaviridae, Papillomavirus Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks